The Justice Department is investigating whether GSK and Sanofi failed to disclose possible carcinogens in heartburn medication. The two companies are being investigated for potential violations of the False Claims Act. (STAT)
Advocacy group petitions the Food and Drug Administration to ban music in drug ads. The group, Knowledge Ecology International, has filed a petition to ban music during the risks and side effects portion of drug ads because it was distracting for viewers. (STAT)
Eli Lilly began a late-stage study of COVID-19 treatment. The study is being conducted in nursing homes to determine whether the drug can prevent the spread of the virus in residents and staff. (Reuters)
Bausch Health has agreed to pay $45 million to settle U.S. government charges. The U.S. said Bausch, then known as Valeant, misled investors. Former Valeant executives also agreed to settle the charges brought by the Securities and Exchange Commission. (BioPharma Dive)
GW Pharmaceuticals has received another FDA approval for its CBD drug, Epidiolex. The cannabidiol drug was approved for a new indication, to treat seizures associated with tuberous sclerosis complex. (MarketWatch)
